National Pharmaceutical Pricing Authority has approved hike in prices of cardiac stents by 4.2 percent, in line with the wholesale price index of the previous calendar year, as per an official statement.
As per the new prices notified by the drug price regulator, a bare metal stent would now cost Rs 8,261, while the drug-eluting stent will cost Rs 30,080.
-
Indian Markets Turning Corner After Two Tough Years, Says Sandeep Tandon -
NDTV Profit Ignite 2026: Experts See Opportunity In Equities, Stay Bullish For Long-Term -
Buy Right, Sit Tight Does Not Work for Individual Stocks, Says Dinshaw Irani -
'Worst Is Behind': Quant MF Sees Market Bottom, Flags 'Extreme Euphoria' In Midcaps -
India's Mutual Fund Industry Could Become A $1 Trillion Opportunity, Say Fund Managers -
'Foreign Investors Are Baraatis': Raamdeo Agrawal's Take On LTCG Tax -
Stay Invested Through Market Cycles: Raamdeo Agrawal at NDTV Profit Ignite -
Ramesh Damani Remains Bullish On India For Next 20-30 Years, Sees Bargains Amid Market Weakness -
CAS Came After A Long Consultation Process: SEBI Chairman Tuhin Kanta Pandey AT NDTV PROFIT IGNITE -
Aim To Cut FPI Onboarding Time From Mth To Five Days: SEBI Chairman Tuhin Kanta Pandey AT NDTV PROFI
The drug pricing authority had earlier revised the prices of stents in February last year. It had increased the prices of bare metal stents to Rs 7,660 from Rs 7,400. On the other hand, it had reduced the price of drug-eluting stents to Rs 27,890 from Rs 30,180.
Also Read | Layoffs Are Rising In Tech, But These Skills Are Helping People Unlock Better Pay
Providing a major relief to lakhs of cardiac patients, the government had for the first time cut prices of life-saving coronary stents by up to 85 percent in February 2017.
Bare metal stents used to cost as much as Rs 45,000 and drug-eluting stents Rs 1.21 lakh prior to the imposition of the price cap in February 2017.
A coronary stent is a tube-shaped device placed in the arteries that supplies blood to heart. It keeps the arteries open in the treatment of coronary heart diseases.
The NPPA also said in a separate statement that it has revised ceiling/retail prices of 871 formulations under Drugs (Price Control) Order, 2013.
Essential Business Intelligence, Sharp Market Insights, Practical Personal Finance Advice, Daily Fuel, Gold and Silver Prices and Latest Stories — On NDTV Profit.
